eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic; Availability - Notice

Draft Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic; Availability - Notice

Document ID: FDA-2005-N-0464-0221
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: E9-108
View Document:  View as format pdf View as format html

Details Information

Document Subtype: N-Notice
Received Date: January 07 2009, at 08:36 AM Eastern Standard Time
Start-End Page: 76364 - 76366
Page Count: 3

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.